List of 2020 Speakers


2020 Conference Speakers



Keynote Speaker:
Michael Varney,
PhD, Executive Vice President, Genentech Research & Early Development

Conference Speakers:
Jeremy Bender, PhD, MBA, Vice President Corporate Development, Gilead Sciences
Mira Chaurushiya,
Principal, 5AM Ventures
Steven Chinowsky,
Partner, Latham & Watkins LLP, San Diego Office
Benjamin Cravatt, Professor, The Scripps Research Institute
Tom Daniel, Venture Partner, ARCH Ventures
Iain Dukes,
Venture Partner, OrbiMed Advisors, LLC
Dan Estes, PhD, Partner, Frazier Healthcare Partners
Evan Fienberg,
CEO, Genesis Therapeutics
Simone Fishburn, Vice President and Editor in Chief, BioCentury Inc. 
Chris Garabedian,
Venture Partner, Perceptive Advisors
Pamela Garzone,
RPH, MSC, PhD, Chief Medical Officer, Calibr, a division of Scripps Research 
Chris Haskell,
PhD, Vice President and Head of West Coast Innovation Center, Bayer
Reza Halse, President, Merck Research Labs Ventures Fund
John Hood, PhD, Founder & Board Chairman, Endeavor Biomedicines
Richard Heyman, Executive Chairman and Co-Founder, Metacrine Inc. 
Catriona Jamieson,
MD, PhD, Deputy Director, UC San Diego Moores Cancer Center; Director, Sanford Stem Cell Clinical Center
Rachna Khosla, MBA, Vice President, Business Development, Amgen
Ravi Kiron, PhD, MBA, Head, BioPharma External Innovation, EMD Serono, Inc.
Nina Kjellson,
General Partner/West Coast, Canaan
Ken Kubota,
VP, Astellas Pharma
Julie Law, Associate Professor, Salk Institute 
Jay Lichter,
PhD, Managing Director, Avalon Ventures
Jonathan Lim,
MD, Managing Partner, City Hill; Venture Partner, ARCH Venture Partners
Angele Maki,
PhD, Vice President, Emerging Technology & Innovation, Eli Lilly & Company
Carole NuechterleinHead, Roche Venture Fund
Michael O’Donnell, Partner, Morrison & Foerster
Eric Owiesny, Partner, Advisory Services, Ernst & Young
Joe Panetta,
President and CEO, Biocom
Scott Platshon,
Principal, EcoR1
Ioannis Sapountzis
, PhD, Corporate Senior Vice President, Business Development, Boehringer Ingelheim Pharmaceuticals, Inc.
Uwe Schoenbeck, PhD, Senior Vice President and Chief Scientific Officer, Emerging Science and Innovation (ES&I), Pfizer Worldwide Research, Development, and Medical
Curtis Scribner, MD, Independent Drugs, Biologics, and Gene Therapy Regulatory Consultant
Bavani Shankar
,
MBA, Head of Transactions, Business Development & Licensing, BioPharmaceuticals R&D, AstraZeneca
Laura Shawver,
PhD, President, CEO, & Director, Synthorx
Jason Skolnik,
Corporate and Securities Partner, Wilson Sonsini Goodrich & Rosati 
Avi Spier
,
Head, Search & Evaluation, Novartis
Jay Stamatis,
MBA, Vice President, Head of Business Development and Acquisitions, AbbVie
Alex Szidon, PhD, Vice President and Head of Business Development, gRED at Genentech
David Szymkowski, Vice President, Cell Biology, Xencor
Ben Thorner,
SVP and Head of BD&L, Merck
Jeffrey Warmke, PhD, Senior Vice President, Search and Evaluation & Alliance Management, Global Business Development, Daiichi Sankyo
Bradley Wolff, Head of West Coast Life Sciences, Citi Corporate and Investment Banking
Timothy Wright,
MD, General Partner,Time BioVentures